市場調査レポート

商品コード

1766395

STIと膣炎のPCR検査市場、規模、シェア、動向、産業分析レポート：病態別（性感染症、膣炎）、検査タイプ別、最終用途別、地域別、2025年～2034年の市場予測

STI and Vaginitis PCR Testing Market Size, Share, Trends, & Industry Analysis Report By Condition [Sexually Transmitted Infections (STIs) and Vaginal Infections], By Test Type, By End Use, and By Region - Market Forecast, 2025-2034

出版日: 2025年06月01日
発行: Polaris Market Research
ページ情報: 英文 125 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 627,555円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 775,215円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 922,875円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=147.66円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、世界のSTIと膣炎のPCR検査市場規模は2034年までに15億7,843万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

STIと膣炎のPCR検査市場は、STIと異なるタイプの膣感染症の病原体特異的検査のためのポリメラーゼ連鎖反応（PCR）技術を用いた高度診断の実施に焦点を当てています。これらの感染症は、クラミジア、淋病、トリコモナスなどの一般的な性感染症（STI）と、細菌性膣症や外陰膣カンジダ症などの膣感染症を含みます。PCR検査は、その高い感度と特異性、そしてどんなに微量であっても原因菌の遺伝物質を正確に捕らえる能力により、他の検査法にはないユニークなものです。この精度の高さは、迅速かつ正確な診断と、疾患の進行やさらなる感染の必要性に対処するための強力かつ的確な治療計画に不可欠です。

この分野の検査に関する期待は、複数の理由から特に楽観的です。地域的にSTIと膣炎の有病率が上昇していることが、正確な診断に対する需要を増大させています。マルチプレックスPCRアッセイ開発のように、分子診断ツールの開発もこの分野の成長を加速させています。単一のサンプルから複数の病原体を検出する能力は、効率を高め、臨床医に診断情報を提供します。さらに、公衆の認識と積極的なスクリーニングキャンペーンは、集団検査の強度を高めており、これは明確に定義された性と生殖の健康に向けた心強い動向です。このような変化には、診断のための正確で信頼できるツールが必要であり、それによって、目的意識をもって戦略的に文字にアクセスできるようにする必要があります。

STIと膣炎のPCR検査市場レポートハイライト

病態別では、性感染症（STI）分野が2024年に大きなシェアを占めました。これは、様々なSTIの世界の有病率の持続的な高さ、その多くが無症状であること、および広範なスクリーニングと公衆衛生管理のためのPCRのような正確で感度の高い診断ツールの極めて重要な必要性によるものです。

検査タイプ別では、STI PCRパネル・セグメントが2024年の市場を独占しました。この優位性は主に、包括的な診断と治療指導に不可欠な、マルチプレックスパネルによる広範な性感染病原体の正確かつ高感度な同時検出に対する重要な要件に起因しています。

最終用途別では、診断検査室部門が2024年に最大のシェアを占めました。これは、専門的なインフラ、高スループット能力、さまざまなヘルスケア環境からの大量の複雑な分子診断検査を処理するために必要な専門知識によるものです。

地域別では、北米がSTIと膣炎のPCR検査市場で大きなシェアを占めています。これは主に、強固なヘルスケアインフラ、性の健康に関する高い意識、PCRベースのアッセイを含む高度診断技術の早期導入に起因しています。アジア太平洋地域のSTIと膣炎のPCR検査市場は、予測期間中に著しい成長率を示すと予測されています。この成長の主な要因は、ヘルスケアインフラの改善、可処分所得の増加、中国やインドなどの国々における性と生殖に関する健康に対する意識の高まりです。

同市場の主要企業には、Hologic, Inc.、BD（Becton, Dickinson and Company）、bioMerieux、F. Hoffmann-La Roche Ltd.、Thermo Fisher Scientific Inc.、Abbott Laboratories、Qiagen、OraSure Technologies、SpeeDx Pty Ltd.などがあります。さらに、Cepheid（Danaher社）やLuminex Corporation（DiaSorin S.p.A.社）のように、より大きな親会社の下で運営されている主要企業もあります。

市場スナップショット
STIと膣炎のPCR検査市場力学
- 促進要因と機会
  - 性感染症と膣炎の蔓延
  - 分子診断における技術の進歩
- 抑制要因と課題
  - 高コストとインフラの障壁
PESTEL分析
STIと膣炎のPCR検査市場のアプリケーション動向
バリューチェーン分析
COVID-19の影響分析

第5章世界のSTIと膣炎のPCR検査市場：病態別

主な調査結果
イントロダクション
性感染症（STI）
膣感染症

第6章世界のSTIと膣炎のPCR検査市場：検査タイプ別

主な調査結果
イントロダクション
STI PCRパネル
膣炎PCRパネル

第7章世界のSTIと膣炎のPCR検査市場：最終用途別

主な調査結果
イントロダクション
病院と診療所
診断検査室
ホームケア/在宅検査
その他

第8章世界のSTIと膣炎のPCR検査市場：地域別

主な調査結果
イントロダクション
- STIと膣炎のPCR検査市場評価：地域別、2020年～2034年
北米
- 北米：病態別、2020～2034年
- 北米：検査タイプ別、2020～2034年
- 北米：最終用途別、2020～2034年
- 米国
- カナダ
欧州
- 欧州：病態別、2020～2034年
- 欧州：検査タイプ別、2020～2034年
- 欧州：最終用途別、2020～2034年
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋地域：病態別、2020～2034年
- アジア太平洋地域：検査タイプ別、2020～2034年
- アジア太平洋地域：最終用途別、2020～2034年
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋地域
中東・アフリカ
- 中東・アフリカ：病態別、2020～2034年
- 中東・アフリカ：検査タイプ別、2020～2034年
- 中東・アフリカ：最終用途別、2020～2034年
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東とアフリカ
ラテンアメリカ
- ラテンアメリカ：病態別、2020-2034年
- ラテンアメリカ：検査タイプ別、2020-2034年
- ラテンアメリカ：最終用途別、2020～2034年
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第9章競合情勢

拡大と買収の分析
- 拡大
- 買収
提携/協業/合意/公開

第10章企業プロファイル

Abbott Laboratories
BD（Becton, Dickinson and Company）
bioMerieux
Cepheid（Danaher）
F. Hoffmann-La Roche Ltd
Hologic, Inc.
Luminex Corporation（DiaSorin S.p. A.）
OraSure Technologies
Qiagen
SpeeDx Pty Ltd
Thermo Fisher Scientific Inc.

図表

List of Tables:

Table 1 Global STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 2 Global STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 3 Global STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 4 North America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 5 North America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 6 North America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 7 U.S.: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 8 U.S.: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 9 U.S.: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 10 Canada: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 11 Canada: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 12 Canada: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 13 Europe: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 14 Europe: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 15 Europe: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 16 UK: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 17 UK: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 18 UK: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 19 France: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 20 France: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 21 France: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 22 Germany: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 23 Germany: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 24 Germany: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 25 Italy: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 26 Italy: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 27 Italy: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 28 Spain: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 29 Spain: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 30 Spain: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 31 Netherlands: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 32 Netherlands: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 33 Netherlands: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 34 Russia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 35 Russia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 36 Russia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 37 Rest of Europe: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 38 Rest of Europe: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 39 Rest of Europe: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 40 Asia Pacific: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 41 Asia Pacific: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 42 Asia Pacific: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 43 China: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 44 China: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 45 China: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 46 India: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 47 India: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 48 India: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 49 Malaysia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 50 Malaysia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 51 Malaysia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 52 Japan: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 53 Japan: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 54 Japan: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 55 Indonesia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 56 Indonesia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 57 Indonesia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 58 South Korea: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 59 South Korea: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 60 South Korea: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 61 Australia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 62 Australia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 63 Australia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 64 Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 65 Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 66 Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 67 Middle East & Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 68 Middle East & Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 69 Middle East & Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 70 Saudi Arabia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 71 Saudi Arabia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 72 Saudi Arabia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 73 UAE: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 74 UAE: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 75 UAE: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 76 Israel: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 77 Israel: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 78 Israel: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 79 South Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 80 South Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 81 South Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 82 Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 83 Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 84 Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 85 Latin America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 86 Latin America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 87 Latin America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 88 Mexico: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 89 Mexico: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 90 Mexico: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 91 Brazil: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 92 Brazil: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 93 Brazil: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 94 Argentina: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 95 Argentina: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 96 Argentina: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
Table 97 Rest of Latin America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
Table 98 Rest of Latin America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
Table 99 Rest of Latin America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)

List of Figures:

Figure 1. Global STI and Vaginitis PCR Testing Market, 2020-2034 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Condition
Figure 7. Global STI and Vaginitis PCR Testing Market, by Condition, 2024 & 2034 (USD Million)
Figure 8. Market by Test Type
Figure 9. Global STI and Vaginitis PCR Testing Market, by Test Type, 2024 & 2034 (USD Million)
Figure 10. Market by End Use
Figure 11. Global STI and Vaginitis PCR Testing Market, by End Use, 2024 & 2034 (USD Million)

Product Code: PM5767

The global STI and vaginitis PCR testing market size is expected to reach USD 1,578.43 million by 2034, according to a new study by Polaris Market Research. The report "STI and Vaginitis PCR Testing Size, Share, Trends & Industry Analysis Report: By Condition [Sexually Transmitted Infections (STIs) and Vaginal Infections], By Test Type, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The STI and vaginitis PCR testing market focuses on the implementation of advanced diagnostics using polymerase chain reaction (PCR) technology for pathogen specific testing of STIs and different types of vaginal infections. These infections encompass common sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and trichomoniasis, alongside vaginal infections such as bacterial vaginosis and vulvovaginal candidiasis. PCR testing is unique among other testing methods due to its high sensitivity and specificity, and its ability to accurately capture the genetic material of causative organisms, no matter how minute the quantities are. This level of precision is essential for prompt and accurate diagnosis and an intense and precise treatment plan that addresses disease progression and further transmission needs.

The expectations related to this area of testing are particularly optimistic for multiple reasons. The rising prevalence of STIs and vaginitis regionally augments the demand for accurate diagnosis. The advancement in molecular diagnostic tools, as in the case of multiplex PCR assay development, is also accelerating growth in this area. The ability to detect multiple pathogens from a single sample increases both efficiency and provides enhanced diagnostic information for clinicians. Moreover, public awareness and proactive screening campaigns heighten population testing intensity, which is an encouraging trend directed toward explicitly defined sexual and reproductive health. Such changes necessitate accurate and reliable tools for diagnosis and, thereby, purposeful and strategic toward letter accessibility.

STI and Vaginitis PCR Testing Market Report Highlights:

By condition, the sexually transmitted infections (STIs) segment held a larger share in 2024, driven by the persistent high global prevalence of various STIs, many of which are asymptomatic, and the crucial need for accurate, sensitive diagnostic tools such as PCR for widespread screening and public health management.

By test type, the STI PCR panels segment dominated the market in 2024. The dominance is primarily attributed to the critical requirement for accurate and sensitive detection of a broad range of sexually transmitted pathogens, often simultaneously through multiplex panels, which are essential for comprehensive diagnosis and treatment guidance.

By end use, the diagnostic laboratories segment held the largest share in 2024, owing to their specialized infrastructure, high-throughput capabilities, and the expertise necessary for processing a large volume of complex molecular diagnostic tests from various healthcare settings.

By region, North America holds a substantial share of the STI and vaginitis PCR testing market. This is largely attributed to the robust healthcare infrastructure, high awareness regarding sexual health, and the early adoption of advanced diagnostic technologies, including PCR-based assays. The Asia Pacific STI and vaginitis PCR testing market is anticipated to exhibit a significant growth rate during the forecast period. This growth is primarily fueled by improving healthcare infrastructure, increasing disposable incomes, and a rising awareness about sexual and reproductive health in countries such as China and India.

A few key players in the market include Hologic, Inc.; BD (Becton, Dickinson and Company); bioMerieux; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Qiagen; OraSure Technologies; and SpeeDx Pty Ltd. Additionally, some key entities operate under larger parent organizations, such as Cepheid (Danaher) and Luminex Corporation (DiaSorin S.p.A.).

Polaris Market Research has segmented the STI and vaginitis PCR testing market report on the basis of condition, test type, end use, and region:

By Condition Outlook (Revenue - USD Million, 2020-2034)

Sexually Transmitted Infections (STIs)

Chlamydia

Gonorrhea

Trichomoniasis

Herpes Simplex Virus (HSV-1 & HSV-2)

Human Papillomavirus (HPV)

Syphilis

Other

Vaginal Infections

Bacterial Vaginosis

Vulvovaginal Candidiasis

Other

By Test Type Outlook (Revenue - USD Million, 2020-2034)

STI PCR Panels

Vaginitis PCR Panels

By End Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals & Clinics

Diagnostic Laboratories

Homecare/At-home Testing

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global STI and Vaginitis PCR Testing Market Insights

4.1. STI and Vaginitis PCR Testing Market - Market Snapshot
4.2. STI and Vaginitis PCR Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Prevalence of STIs and Vaginitis
  - 4.2.1.2. Technological Advancements in Molecular Diagnostics
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost and infrastructure barriers
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. STI and Vaginitis PCR Testing Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global STI and Vaginitis PCR Testing Market, by Condition

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
5.3. Sexually Transmitted Infections (STIs)
- 5.3.1. Global STI and Vaginitis PCR Testing Market, by Sexually Transmitted Infections (STIs), by Region, 2020-2034 (USD Million)
- 5.3.2. Chlamydia
- 5.3.3. Gonorrhea
- 5.3.4. Trichomoniasis
- 5.3.5. Herpes Simplex Virus (HSV-1 & HSV-2)
- 5.3.6. Human Papillomavirus (HPV)
- 5.3.7. Syphilis
- 5.3.8. Other
5.4. Vaginal Infections
- 5.4.1. Global STI and Vaginitis PCR Testing Market, by Vaginal Infections, by Region, 2020-2034 (USD Million)
- 5.4.2. Bacterial Vaginosis
- 5.4.3. Vulvovaginal Candidiasis
- 5.4.4. Other

6. Global STI and Vaginitis PCR Testing Market, by Test Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
6.3. STI PCR Panels
- 6.3.1. Global STI and Vaginitis PCR Testing Market, by STI PCR Panels, by Region, 2020-2034 (USD Million)
6.4. Vaginitis PCR Panels
- 6.4.1. Global STI and Vaginitis PCR Testing Market, by Vaginitis PCR Panels, by Region, 2020-2034 (USD Million)

7. Global STI and Vaginitis PCR Testing Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
7.3. Hospitals & Clinics
- 7.3.1. Global STI and Vaginitis PCR Testing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Million)
7.4. Diagnostic Laboratories
- 7.4.1. Global STI and Vaginitis PCR Testing Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
7.5. Homecare/At-home Testing
- 7.5.1. Global STI and Vaginitis PCR Testing Market, by Homecare/At-home Testing, by Region, 2020-2034 (USD Million)
7.6. Others
- 7.6.1. Global STI and Vaginitis PCR Testing Market, by Others, by Region, 2020-2034 (USD Million)

8. Global STI and Vaginitis PCR Testing Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. STI and Vaginitis PCR Testing Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. STI and Vaginitis PCR Testing Market - North America
- 8.3.1. North America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
- 8.3.2. North America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
- 8.3.3. North America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.3.4. STI and Vaginitis PCR Testing Market - U.S.
  - 8.3.4.1. U.S.: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.3.4.2. U.S.: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.3.4.3. U.S.: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.3.5. STI and Vaginitis PCR Testing Market - Canada
  - 8.3.5.1. Canada: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.3.5.2. Canada: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.3.5.3. Canada: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
8.4. STI and Vaginitis PCR Testing Market - Europe
- 8.4.1. Europe: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
- 8.4.2. Europe: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
- 8.4.3. Europe: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.4.4. STI and Vaginitis PCR Testing Market - UK
  - 8.4.4.1. UK: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.4.4.2. UK: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.4.4.3. UK: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.4.5. STI and Vaginitis PCR Testing Market - France
  - 8.4.5.1. France: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.4.5.2. France: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.4.5.3. France: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.4.6. STI and Vaginitis PCR Testing Market - Germany
  - 8.4.6.1. Germany: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.4.7. STI and Vaginitis PCR Testing Market - Italy
  - 8.4.7.1. Italy: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.4.8. STI and Vaginitis PCR Testing Market - Spain
  - 8.4.8.1. Spain: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.4.9. STI and Vaginitis PCR Testing Market - Netherlands
  - 8.4.9.1. Netherlands: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.4.10. STI and Vaginitis PCR Testing Market - Russia
  - 8.4.10.1. Russia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.4.11. STI and Vaginitis PCR Testing Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
8.5. STI and Vaginitis PCR Testing Market - Asia Pacific
- 8.5.1. Asia Pacific: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.5.4. STI and Vaginitis PCR Testing Market - China
  - 8.5.4.1. China: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.5.4.2. China: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.5.4.3. China: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.5.5. STI and Vaginitis PCR Testing Market - India
  - 8.5.5.1. India: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.5.5.2. India: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.5.5.3. India: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.5.6. STI and Vaginitis PCR Testing Market - Malaysia
  - 8.5.6.1. Malaysia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.5.7. STI and Vaginitis PCR Testing Market - Japan
  - 8.5.7.1. Japan: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.5.8. STI and Vaginitis PCR Testing Market - Indonesia
  - 8.5.8.1. Indonesia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.5.9. STI and Vaginitis PCR Testing Market - South Korea
  - 8.5.9.1. South Korea: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.5.10. STI and Vaginitis PCR Testing Market - Australia
  - 8.5.10.1. Australia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.5.11. STI and Vaginitis PCR Testing Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
8.6. STI and Vaginitis PCR Testing Market - Middle East & Africa
- 8.6.1. Middle East & Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.6.4. STI and Vaginitis PCR Testing Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.6.5. STI and Vaginitis PCR Testing Market - UAE
  - 8.6.5.1. UAE: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.6.6. STI and Vaginitis PCR Testing Market - Israel
  - 8.6.6.1. Israel: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.6.7. STI and Vaginitis PCR Testing Market - South Africa
  - 8.6.7.1. South Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.6.8. STI and Vaginitis PCR Testing Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
8.7. STI and Vaginitis PCR Testing Market - Latin America
- 8.7.1. Latin America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
- 8.7.2. Latin America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
- 8.7.3. Latin America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.7.4. STI and Vaginitis PCR Testing Market - Mexico
  - 8.7.4.1. Mexico: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.7.5. STI and Vaginitis PCR Testing Market - Brazil
  - 8.7.5.1. Brazil: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.7.6. STI and Vaginitis PCR Testing Market - Argentina
  - 8.7.6.1. Argentina: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
- 8.7.7. STI and Vaginitis PCR Testing Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. BD (Becton, Dickinson and Company)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. bioMerieux
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Cepheid (Danaher)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. F. Hoffmann-La Roche Ltd
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Hologic, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Luminex Corporation (DiaSorin S.p. A.)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. OraSure Technologies
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Qiagen
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. SpeeDx Pty Ltd
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Thermo Fisher Scientific Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development

STIと膣炎のPCR検査市場、規模、シェア、動向、産業分析レポート：病態別（性感染症、膣炎）、検査タイプ別、最終用途別、地域別、2025年～2034年の市場予測

STI and Vaginitis PCR Testing Market Size, Share, Trends, & Industry Analysis Report By Condition [Sexually Transmitted Infections (STIs) and Vaginal Infections], By Test Type, By End Use, and By Region - Market Forecast, 2025-2034

STIと膣炎のPCR検査市場レポートハイライト

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界のSTIと膣炎のPCR検査市場の洞察

第5章世界のSTIと膣炎のPCR検査市場：病態別

第6章世界のSTIと膣炎のPCR検査市場：検査タイプ別

第7章世界のSTIと膣炎のPCR検査市場：最終用途別

第8章世界のSTIと膣炎のPCR検査市場：地域別

第9章競合情勢

第10章企業プロファイル

List of Tables:

List of Figures:

STI and Vaginitis PCR Testing Market Report Highlights:

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global STI and Vaginitis PCR Testing Market Insights

5. Global STI and Vaginitis PCR Testing Market, by Condition

6. Global STI and Vaginitis PCR Testing Market, by Test Type

7. Global STI and Vaginitis PCR Testing Market, by End Use

8. Global STI and Vaginitis PCR Testing Market, by Geography

9. Competitive Landscape

10. Company Profiles

STIと膣炎のPCR検査市場、規模、シェア、動向、産業分析レポート：病態別（性感染症、膣炎）、検査タイプ別、最終用途別、地域別、2025年～2034年の市場予測

STI and Vaginitis PCR Testing Market Size, Share, Trends, & Industry Analysis Report By Condition [Sexually Transmitted Infections (STIs) and Vaginal Infections], By Test Type, By End Use, and By Region - Market Forecast, 2025-2034

STIと膣炎のPCR検査市場レポートハイライト

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のSTIと膣炎のPCR検査市場の洞察

第5章 世界のSTIと膣炎のPCR検査市場：病態別

第6章 世界のSTIと膣炎のPCR検査市場：検査タイプ別

第7章 世界のSTIと膣炎のPCR検査市場：最終用途別

第8章 世界のSTIと膣炎のPCR検査市場：地域別

第9章 競合情勢

第10章 企業プロファイル

List of Tables:

List of Figures:

STI and Vaginitis PCR Testing Market Report Highlights:

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global STI and Vaginitis PCR Testing Market Insights

5. Global STI and Vaginitis PCR Testing Market, by Condition

6. Global STI and Vaginitis PCR Testing Market, by Test Type

7. Global STI and Vaginitis PCR Testing Market, by End Use

8. Global STI and Vaginitis PCR Testing Market, by Geography

9. Competitive Landscape

10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界のSTIと膣炎のPCR検査市場の洞察

第5章世界のSTIと膣炎のPCR検査市場：病態別

第6章世界のSTIと膣炎のPCR検査市場：検査タイプ別

第7章世界のSTIと膣炎のPCR検査市場：最終用途別

第8章世界のSTIと膣炎のPCR検査市場：地域別

第9章競合情勢

第10章企業プロファイル